COVID-19 and social distancing have disrupted traditional data collection methods in the life insurance underwriting process. This also implicates expected mortality experience and insurance pricing. Emile Elefteriadis, FCIA, and Norm Leblond join us to discuss these changes, and what we may see moving forward.
Jing Lang, Vice-President, Product Manager at iptiQ, provides an overview of various products and underwriting processes, and speaks on the impact of COVID-19 on the risk assessment process.
In this article, Mary Stock and Trudy Engel discuss a few key considerations that relate to the economic assumption setting process in these unprecedented times and will highlight a few CIA documents that may be worth reviewing.
The impact of COVID-19 on morbidity experience is still unknown at this stage. In this article, Mario St-Hilaire and Steve Turmel discuss the key considerations that relate to the assumption-setting process for morbidity in these unprecedented times.
The experience related to the impact of COVID-19 on lapse/persistency of life and health insurance contracts is just starting to emerge and life insurers are monitoring this experience closely. Amal Rajwani and Dan Doyle discuss short-term and long-term considerations in relation to lapse and persistency.
Canadian Institute of Actuaries
360 Albert Street, Suite 1740
Ottawa, Ontario K1R 7X7
SeeingBeyondRisk@cia-ica.ca